Dexloxiglumide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDexloxiglumide
Drug Alias Name右氯谷胺dexloxiglumidumdexloxiglumidedexloxiglumidaCR-2017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin A receptor antagonists
TargetsCholecystokinin A receptor
Therapy Area/IndicationsDyspepsiaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDyspepsiaIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank